GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.
about
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerGPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndromeEpigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia.
P2860
GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@ast
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@en
type
label
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@ast
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@en
prefLabel
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@ast
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@en
P2093
P2860
P1476
GPX3 hypermethylation serves a ...... non-M3 acute myeloid leukemia.
@en
P2093
Dong-Ming Yao
Ji-Chun Ma
Jing-Dong Zhou
Xiang-Mei Wen
Ying-Ying Zhang
P2860
P304
P577
2015-04-15T00:00:00Z